BioCorRx Completes Pre-IND Meeting with FDA; Reports Company to Move Forward with BICX102
Jan 26, 2018 12:30 pm UTC| Business
ANAHEIM, CA , Jan. 26, 2018 -- BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that it held...
Toronto Sees Record Breaking 2017 for Real Estate, With Robust Activity Poised to Continue in 2018
Jan 26, 2018 12:30 pm UTC| Business
TORONTO, Jan. 26, 2018 -- Altus Group Limited (“Altus Group”) (TSX:AIF), a leading provider of commercial real estate services, software and data solutions, today released results of the 2018 GTA Flash Report, which...
Jan 26, 2018 12:30 pm UTC| Business
NEW YORK, Jan. 26, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Del Frisco's...
eEuroparts.com Partners with ROWE Motor Oil for 2018 Racing Season
Jan 26, 2018 12:00 pm UTC| Business
WINDSOR, Conn., Jan. 26, 2018 -- eEuroparts.com, a leading retailer of German and Swedish automotive repair parts, announces a 2018 racing season partnership with ROWE Motor Oil, a leading German manufacturer of HIGHTEC...
Alpine 4 Technologies announces its new Blockchain Enterprises Operating Systems, SPECTRUMebos
Jan 26, 2018 12:00 pm UTC| Business
PHOENIX, Ariz., Jan. 26, 2018 -- via OTC PR WIRE -- Alpine 4 Technologies (OTCQB:ALPP) announced today that it has begun two pilots of SPECTRUMebos, a blockchain Enterprise Business Operating System, in its subsidiaries...
OneSoft to Present at Cantech Investment Conference
Jan 26, 2018 12:00 pm UTC| Business
Edmonton, Alberta, Jan. 26, 2018 -- OneSoft Solutions Inc. (the “Company” or “OneSoft”) (TSX-V:OSS, OTCQB:OSSIF) is pleased to announce its upcoming attendance at the fifth annual Cantech Investment Conference 2018 on...
Jan 26, 2018 12:00 pm UTC| Business
UTRECHT, the Netherlands, Jan. 26, 2018 -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the first patient...